Migraines » Blog Archive » Actavis Receives Approval Generic Inderal(R) LA Capsules In The U.S.

Categories

Add to Technorati Favorites

Recent Posts

Telcagepant Proven As A Safe And Effective Migraine Treatment In Phase III Trial
Patent Foramen Ovale Closure Extremely Promising For Stroke Prevention And Treatment Of Migraine
Overuse Of Narcotics And Barbiturates May Make Migraine Worse
1 In 4 Gulf War Veterans Suffer From Illness Caused By Toxic Exposure
500-Patient Study Measuring Cognitive Processing Efficiency During Migraine Attacks
Breakthrough’s Comment On Research Suggesting Women Who Have Migraines Have A Reduced Risk Of Breast Cancer
Pycnogenol Cut Jetlag Symptoms In Half For Passengers Taking 7- To 9-hour Flights
Women Who Have Migraines Have Lower Breast Cancer Risk
Doctors Stress Pressing Need For Research Into The Best Treatment For Medication Overuse Headaches
Minster Pharmaceuticals Plc Announces Positive Results From Phase II Trial Of Migraine With Aura

Blogroll

Medical Links

Aches And Pains

Actavis Receives Approval Generic Inderal(R) LA Capsules In The U.S.

August 22nd, 2007 by admin

Actavis Group, the international generic pharmaceuticals company, today announced that it has received approval from the U.S. Food & Drug Administration to market Propranolol Hydrochloride extended-release capsules. Distribution of the product will commence immediately. [click link for full article]

More: continued here

Posted in treatment for migraine headaches |

Leave a Comment